BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36810128)

  • 21. Does surgically resected small-cell lung cancer without lymph node involvement benefit from prophylactic cranial irradiation?
    Lou Y; Zhong R; Xu J; Qiao R; Teng J; Zhang Y; Zhang X; Chu T; Zhong H; Han B
    Thorac Cancer; 2020 May; 11(5):1239-1244. PubMed ID: 32142599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selection of candidates for surgery as local therapy among early-stage small cell lung cancer patients: a population-based analysis.
    Jin K; Zhang K; Zhou F; Dai J; Zhang P; Jiang G
    Cancer Commun (Lond); 2018 Mar; 38(1):5. PubMed ID: 29764484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prognostic factors of lymph node-negative metastasis gastric cancer].
    Sun D; Xu H; Huang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymph node staging by endobronchial ultrasound-guided transbronchial needle aspiration in patients with small cell lung cancer.
    Wada H; Nakajima T; Yasufuku K; Fujiwara T; Yoshida S; Suzuki M; Shibuya K; Hiroshima K; Nakatani Y; Yoshino I
    Ann Thorac Surg; 2010 Jul; 90(1):229-34. PubMed ID: 20609781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic impact of clinical variables on surgically resected small-cell lung cancer: Results of a retrospective multicenter analysis (FIGHT002A and HOT1301A).
    Yokouchi H; Ishida T; Yamazaki S; Kikuchi H; Oizumi S; Uramoto H; Tanaka F; Harada M; Akie K; Sugaya F; Fujita Y; Fukuhara T; Takamura K; Kojima T; Harada T; Higuchi M; Matsuura Y; Honjo O; Minami Y; Watanabe N; Nishihara H; Suzuki H; Dosaka-Akita H; Isobe H; Nishimura M; Munakata M
    Lung Cancer; 2015 Dec; 90(3):548-53. PubMed ID: 26604032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics and prognostic factors of surgically resected combined small cell lung cancer: a retrospective study.
    Lei Y; Feng H; Qiang H; Shang Z; Chang Q; Qian J; Zhang Y; Zhong R; Fan X; Chu T
    Lung Cancer; 2020 Aug; 146():244-251. PubMed ID: 32592985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of lymph node status in completely resected IIIa/N2 small cell lung cancer: importance of subcarinal station metastases.
    Qiao R; Zhong R; Xu J; Zhang Y; Zhang B; Wang S; Lou Y; Chen D; Chang Q; Zhao Y; Han B
    J Cardiothorac Surg; 2019 Mar; 14(1):63. PubMed ID: 30925891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Choice of surgical procedure - lobectomy, segmentectomy, or wedge resection - for patients with stage T1-2N0M0 small cell lung cancer: A population-based study.
    Liu Y; Shan L; Shen J; Liu L; Wang J; He J; He Q; Jiang L; Guo M; Chen X; Zeng H; Xia X; Peng G; Liang W; He J
    Thorac Cancer; 2019 Apr; 10(4):593-600. PubMed ID: 30854808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is neoadjuvant chemotherapy mandatory for limited-disease small-cell lung cancer?
    Xu YJ; Zheng H; Gao W; Jiang GN; Xie HK; Chen C; Fei K
    Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):887-93. PubMed ID: 25156899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Propensity score matched analysis for the role of surgery in stage Ⅲ small cell lung cancer based on the eighth edition of the TNM classification: a population study of the US SEER database and a Chinese hospital.
    Gao L; Shen L; Wang K; Lu S
    Lung Cancer; 2021 Dec; 162():54-60. PubMed ID: 34739854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term results of postoperative unsuspected small cell lung cancer on real-world data.
    Guo J; Shen L; Ren Z; Liu Y; Liang C
    BMC Cancer; 2022 Dec; 22(1):1256. PubMed ID: 36461029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognostic value of AJCC TNM Staging 7th edition in limited-stage small cell lung cancer: validation in 437 patients].
    Zhang W; Zhu H; Zhou Z; Feng Q; Chen D; Zhang H; Xiao Z; Wang L
    Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):917-22. PubMed ID: 26887621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical resection should be considered for stage I and II small cell carcinoma of the lung.
    Weksler B; Nason KS; Shende M; Landreneau RJ; Pennathur A
    Ann Thorac Surg; 2012 Sep; 94(3):889-93. PubMed ID: 22429675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in the prognostic implication of ground-glass opacity on CT according to pathological nodal status in lung cancers treated with lobectomy or pneumonectomy.
    Park S; Lee SM; Choe J; Choi S; Kim S; Do KH; Seo JB
    Eur Radiol; 2022 Jul; 32(7):4405-4413. PubMed ID: 35141781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Value of Metabolic Parameters of Metastatic Lymph Nodes on
    Jin F; Qu B; Fu Z; Zhang Y; Han A; Kong L; Yu J
    Clin Lung Cancer; 2018 Jan; 19(1):e101-e108. PubMed ID: 28690012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral-type small cell lung cancer is associated with better survival and higher frequency of interstitial lung disease.
    Kanaji N; Sakai K; Ueda Y; Miyawaki H; Ishii T; Watanabe N; Kita N; Kadota K; Kadowaki N; Bandoh S
    Lung Cancer; 2017 Jun; 108():126-133. PubMed ID: 28625624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Outcomes Following Stereotactic Body Radiation Therapy (SBRT) for Stage I Medically Inoperable Small Cell Lung Carcinoma: A Multi-Institutional Analysis From the RSSearch Patient Registry.
    Singh R; Ansinelli H; Sharma D; Jenkins J; Davis J; Vargo JA; Sharma S
    Am J Clin Oncol; 2019 Jul; 42(7):602-606. PubMed ID: 31232723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The applicability of the proposed IASLC staging revisions to small cell lung cancer (SCLC) with comparison to the current UICC 6th TNM Edition.
    Ignatius Ou SH; Zell JA
    J Thorac Oncol; 2009 Mar; 4(3):300-10. PubMed ID: 19156001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bolstering the case for lobectomy in stages I, II, and IIIA small-cell lung cancer using the National Cancer Data Base.
    Combs SE; Hancock JG; Boffa DJ; Decker RH; Detterbeck FC; Kim AW
    J Thorac Oncol; 2015 Feb; 10(2):316-23. PubMed ID: 25319182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.